The initial attempt to uncover residues with a functional role in a sea anemone toxin was by chemical modifications of Av2 (
Barhanin et al., 1981). This study raised the putative role in bioactivity of Asp-7, Asp-9, Arg-14 His-32, His-37, Lys-35, Lys-36, Lys-46 and the C-terminus. However, since (i) only charged residues were modified; (ii) in many instances a number of residues have been modified simultaneously; and (iii) the toxin fold might have been altered, the significance of these results is questionable. Indeed, mutagenesis of Av2 and other Type I toxins has provided a different picture (
Blumenthal and Seibert, 2003;
Moran et al., 2006).
The Type I sea anemone toxin that was most extensively studied during the last decade was ApB (
Gallagher and Blumenthal, 1992). With the advent of its recombinant production using an
Escherichia coli expression system, Blumenthal and his colleagues were able to modify the toxin residue by residue and to assess the effect of these substitutions on bioactivity. All ApB mutants were assayed either on cardiac rNa
v1.5 and brain rNa
v1.2a channels transiently expressed in HEK cells, or mammalian cell lines that constitutively express these channels among a minority of other channel subtypes. These studies have suggested a bioactive role for Arg-12, Asn-16, Leu-18, Ser-19, Trp-33, Lys-37 and Lys-49, of which most bioactive residues were associated with the Arg-14 loop and with the substitutions of Leu-18 having the strongest effect on ApB activity (
Blumenthal and Seibert, 2003;
Khera and Blumenthal, 1996;
Dias-Kadambi et al., 1996a;
Dias-Kadambi et al., 1996b;
Kelso et al., 1996;
Seibert et al., 2004; and ). In contrast to the results obtained by chemical modifications of Av2 (
Barhanin et al., 1981), this mutagenic analysis has indicated that Arg-14, His-34 and His-39 have no bioactive role (
Khera and Blumenthal, 1994,
1996).
Recombinant expression of novel neurotoxin transcripts from
Anthopleura of unknown species and activity assays using the contractile force of isolated rat atria, suggested that residues at sites 14, 22 and 25 might have a bioactive role (
Wang et al., 2004). Nevertheless, these results await further validation using electrophysiological, binding and toxicity assays more common in the analysis of toxins (
Blumenthal and Seibert, 2003;
Moran et al., 2006).
Functional expression of Av2 enabled thorough alanine scanning and elucidation of its bioactive surface toward insects (
Moran et al., 2006). Analysis of all mutants in toxicity to blowfly larvae and binding assays on cockroach neuronal membranes revealed a functional role for Val-2, Leu-5, Asn-16, Leu-18 and Ile-41 ( and ). Further electrophysiological analysis of these mutants against at hNa
v1.5, indicated a bioactive surface toward the mammalian channel similar to that toward insect channels with the exception of Ser-19, whose substitution affected only the activity only at the cardiac channel. Av2 and ApB are 79% identical in sequence and excluding Arg-12 and Lys-49, all other residues shown to be important in Av2 appear also in ApB (). However, a major variation between both toxins is the functional role proposed for Trp-33 and Lys-37 in ApB, whereas substitution of their Trp-31 and Lys-35 equivalents in Av2 had no effect on the insecticidal activity, and affected only slightly the activity at Na
v1.5 (
Moran et al., 2006). Moreover, of the four functional aliphatic residues on the Av2 surface, only Leu-18 was ascribed to the anti-mammalian bioactive surface of ApB (
Dias-Kadambi et al., 1996b). These glaring differences suggest that despite some commonality in the bioactive surface of Av2 and ApB, the two toxins may interact differently with receptor site-3 on insect and mammalian Na
vs. This assumption is corroborated by findings of
Benzinger and co-workers (1997) that have suggested about differences in the binding sites of ApA and ApB on rat skeletal muscle and cardiac Na
vs.
Mutagenesis of the glycine residues spanning the flexible Arg-14 loop severely hampered the ability of ApB and Av2 to affect Na
vs (
Seibert et al., 2003;
Moran et al., 2006). On the basis of these results and the fact that glycines usually are found in protein sequences at positions that may enlarge structural flexibility, it was proposed that the freedom of the Arg-14 loop to tilt is an important feature for toxin interaction with the receptor site. Another residue whose substitution by alanine affects toxin action is the conserved Asp-9 (
Khera and Blumenthal, 1996;
Moran et al., 2006; ). Because substitution D9N had only little effect on toxicity, the carboxyl group of Asp-9 is not critical for Av2 and ApB activity. As may be inferred from the NMR structures of ApA and ApB, a hydrogen bond exists between the carbonyl group at the side chain of Asp-9 and the amine of Cys-6 (
Pallaghy et al., 1995;
Monks et al., 1995). Theoretically this bond should be maintained when the aspartate is substituted by asparagine.
Khera and Blumenthal (1996) reported that Asp-9 is critical for proper folding of recombinant ApB on the basis of the prominent decline in polypeptide yield when mutated at this position. However, the same phenomenon was not observed in Asp-9 mutants of Av2 (
Moran et al., 2006), suggesting that the role of the hydrogen bond formed by the carbonyl of Asp-9 with Cys-6 is to limit the free tilting of the Arg-14 loop. Assuming that the binding of sea anemone toxins to receptor site-3 includes a step of induced fit (
Koshland, 1958), which involves the Arg-14 loop, it is possible that its flexibility enables adoption of a shape necessary for binding. Yet, it cannot be ruled out that the carbonyl of Asp-9 simply interacts with the Na
v receptor site.
Although Type II sea anemone toxins have been studied at the physiological level, none of them was analyzed using a molecular approach. their study at the molecular level was limited and focused on the charged residues in Sh-I of
Stichodactyla helianthus (
Pennington et al. 1990). It was shown that substitutions of Lys-4, Asp-6, Asp-7, Glu-8 and Asp-11 impaired severely the activity of Sh-I with no effect on its structure, suggesting that the bioactive surface of this toxin is highly charged. Although diverged from a putative common ancestor (Ishida et al., 1996;
Moran and Gurevitz, 2006), sequence comparison of Type II toxins with Type I toxins reveals less than 50% identity, and the bioactive residues in both toxin types differ determined in Type I to be involved in bioactivity are not conserved in Type II toxins (). Despite the difference, both toxin types exert similar effects on a crustacean axon (
Rathmayer et al., 1976;
Salgado and Kem, 1992). Even more confusing is the fact that CLX-I (also known as CpI) of
C. parasitica, which hardly shares any sequence similarity with other Type I and Type II sea anemone toxins, affects the crustacean axon in a very similar fashion (
Cariello et al., 1989;
Salgado and Kem, 1992). It seems therefore that the similar general structure, maintained by a conserved framework of 3 three disulfide cysteine bonds, and the flexibility of the Arg-14 loop, are of major importance in the ability of sea anemone toxins to bind at receptor site-3 of Na
vs. However, the question of how this receptor is recognized by a variety of toxin faces is still unclear.
Recombinant expression and mutagenesis of Av3 revealed that the bioactive surface of this toxin is clustered at one hemisphere of the molecule and consists of Arg-1 and a patch of hydrophobic residues, Pro-5, Tyr-7, Trp-8, Pro-12, Trp-13 and Tyr-18 (). This bioactive surface is much more condensed than those of the Type I sea anemone toxins ApB (
Seibert et al., 2004) and Av2 (
Moran et al., 2006). While the bioactive surface of Av2 lacks aromatic residues, the bioactive surface of Av3 heavily depends on them (). Moreover, some of the residues most critical for Av2 activity appear on the flexible Arg-14 loop, whereas such flexible determinant does not exist in Av3 (
Manoleras and Norton, 1994). The bioactive surface of Av3 [245 Å
2 (1 Å=0.1 nm)] is considerably smaller than those of scorpion α-toxins (e.g. 430 Å
2 for LqhαIT), whose bioactive surfaces are divided into two major amino acid clusters (
Karbat et al., 2004,
2007;
Ye et al., 2005; ). These prominent differences imply that the three toxin types interact differently with receptor site-3 on DmNa
v1, providing further support for the high heterogeneity of this site (
Gordon et al., 1996,
2007;
Moran et al., 2007).